Beigene Stock Net Income

BEIGF Stock   25.29  0.00  0.00%   
As of the 31st of January, BeiGene shows the Standard Deviation of 6.92, mean deviation of 1.7, and Risk Adjusted Performance of 0.1007. BeiGene technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm BeiGene coefficient of variation, total risk alpha, as well as the relationship between the Total Risk Alpha and skewness to decide if BeiGene is priced correctly, providing market reflects its regular price of 25.29 per share. Given that BeiGene has variance of 47.91, we suggest you to validate BeiGene's prevailing market performance to make sure the company can sustain itself at a future point.
BeiGene's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing BeiGene's valuation are provided below:
BeiGene does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
It's important to distinguish between BeiGene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BeiGene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, BeiGene's market price signifies the transaction level at which participants voluntarily complete trades.

BeiGene 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BeiGene's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BeiGene.
0.00
11/02/2025
No Change 0.00  0.0 
In 3 months and 1 day
01/31/2026
0.00
If you would invest  0.00  in BeiGene on November 2, 2025 and sell it all today you would earn a total of 0.00 from holding BeiGene or generate 0.0% return on investment in BeiGene over 90 days. BeiGene is related to or competes with Columbia Sportswear, JB Hunt, Canlan Ice, Academy Sports, Perseus Mining, Coeur Mining, and Nicola Mining. More

BeiGene Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BeiGene's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BeiGene upside and downside potential and time the market with a certain degree of confidence.

BeiGene Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for BeiGene's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BeiGene's standard deviation. In reality, there are many statistical measures that can use BeiGene historical prices to predict the future BeiGene's volatility.
Hype
Prediction
LowEstimatedHigh
18.1525.2932.43
Details
Intrinsic
Valuation
LowRealHigh
19.9527.0934.23
Details
Naive
Forecast
LowNextHigh
19.4426.5833.72
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
25.2925.2925.29
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as BeiGene. Your research has to be compared to or analyzed against BeiGene's peers to derive any actionable benefits. When done correctly, BeiGene's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in BeiGene.

BeiGene January 31, 2026 Technical Indicators

BeiGene Backtested Returns

BeiGene appears to be somewhat reliable, given 3 months investment horizon. BeiGene secures Sharpe Ratio (or Efficiency) of 0.13, which signifies that the company had a 0.13 % return per unit of risk over the last 3 months. By analyzing BeiGene's technical indicators, you can evaluate if the expected return of 0.93% is justified by implied risk. Please makes use of BeiGene's Mean Deviation of 1.7, standard deviation of 6.92, and Risk Adjusted Performance of 0.1007 to double-check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, BeiGene holds a performance score of 10. The firm shows a Beta (market volatility) of 0.69, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, BeiGene's returns are expected to increase less than the market. However, during the bear market, the loss of holding BeiGene is expected to be smaller as well. Please check BeiGene's information ratio, as well as the relationship between the skewness and day median price , to make a quick decision on whether BeiGene's price patterns will revert.

Auto-correlation

    
  0.00  

No correlation between past and present

BeiGene has no correlation between past and present. Overlapping area represents the amount of predictability between BeiGene time series from 2nd of November 2025 to 17th of December 2025 and 17th of December 2025 to 31st of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BeiGene price movement. The serial correlation of 0.0 indicates that just 0.0% of current BeiGene price fluctuation can be explain by its past prices.
Correlation Coefficient0.0
Spearman Rank Test1.0
Residual Average0.0
Price Variance0.0
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, BeiGene reported net income of (1.41 Billion). This is 514.13% lower than that of the Healthcare sector and significantly lower than that of the Biotechnology industry. The net income for all United States stocks is significantly higher than that of the company.

BeiGene Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BeiGene's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of BeiGene could also be used in its relative valuation, which is a method of valuing BeiGene by comparing valuation metrics of similar companies.
BeiGene is currently under evaluation in net income category among its peers.

BeiGene Fundamentals

About BeiGene Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze BeiGene's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BeiGene using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BeiGene based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in BeiGene Pink Sheet

When determining whether BeiGene offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BeiGene's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Beigene Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Beigene Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BeiGene. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in census.
For more detail on how to invest in BeiGene Pink Sheet please use our How to Invest in BeiGene guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
It's important to distinguish between BeiGene's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BeiGene should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, BeiGene's market price signifies the transaction level at which participants voluntarily complete trades.